Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine.

Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine.
复制标题

DOI:
10.1084/jem.20022218
复制
发表时间:
2003-08-18
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
Fukuda T
Fukuda T
中科院分区:
其他
文献类型:
--
作者:
Honda K;Arima M;Cheng G;Taki S;Hirata H;Eda F;Fukushima F;Yamaguchi B;Hatano M;Tokuhisa T;Fukuda T

文献摘要

参考文献

被引文献

相似文献

已知PGD 2是肥大细胞释放的脂质介质,参与过敏反应。然而,PGD 2促进这些反应的机制仍不清楚。我们建立了一种新的哮喘实验模型,可以直接评估PGD 2在气道炎症中的作用。抗原致敏小鼠暴露于雾化前列腺素D2(PGD 2)1天前的挑战与低剂量雾化抗原。PGD 2预处理小鼠支气管肺泡灌洗液中嗜酸性粒细胞、淋巴细胞和巨噬细胞的数量以及IL-4和IL-5的水平均高于对照小鼠。巨噬细胞源性趋化因子(MDC),一种Th 2细胞的趋化因子,在PGD 2预处理的小鼠中的表达高于对照组。给PGD_2预处理的小鼠注射抗MDC抗体可明显抑制抗原攻击后的炎性细胞浸润和Th_2细胞因子的产生。这些结果表明,PGD 2通过诱导MDC加速Th 2型炎症。我们的研究结果表明,这种机制可能在人类哮喘的发展中起着关键作用,MDC可能是治疗干预的靶分子。
PGD2, a lipid mediator released from mast cells, is known to participate in allergic reactions. However, the mechanism by which PGD2 contributes to such reactions remains unclear. We established a novel experimental model of asthma that permitted direct assessment of the role of PGD2 in airway inflammation. Antigen-sensitized mice were exposed to aerosolized prostaglandin D2 (PGD2) 1 d before challenge with low-dose aerosolized antigen. Not only the numbers of eosinophils, lymphocytes, and macrophages but also the levels of IL-4 and IL-5 in bronchoalveolar lavage fluid were higher in PGD2-pretreated mice than in control mice. The expression of macrophage-derived chemokine (MDC), a chemoattractant for Th2 cells, was greater in PGD2-pretreated mice than in control. Injection of anti-MDC antibody into PGD2-pretreated mice markedly inhibited inflammatory cell infiltration as well as Th2 cyto-kine production after antigen challenge. These results indicate that PGD2 accelerates Th2 type inflammation by induction of MDC. Our results suggest that this mechanism may play a key role in the development of human asthma and that MDC might be a target molecule for therapeutic intervention.
DOI: 10.1164/rccm.2105079
发表时间: 2002-08-01
影响因子: 24.7
作者:
Cheng, G;Arima, M;Fukuda, T
通讯作者: Fukuda, T
DOI: 10.1111/j.1476-5381.1976.tb07446.x
发表时间: 1976-01-01
影响因子: 7.3
作者:
FLOWER, RJ;HARVEY, EA;KINGSTON, WP
通讯作者: KINGSTON, WP
DOI: 10.1164/ajrccm.156.3.9606031
发表时间: 1997-09-01
影响因子: 24.7
作者:
Hamelmann, E;Schwarze, J;Gelfand, EW
通讯作者: Gelfand, EW
DOI: 10.4049/jimmunol.168.1.443
发表时间: 2002-01-01
影响因子: 4.4
作者:
Fujitani, Y;Kanaoka, Y;Urade, Y
通讯作者: Urade, Y
DOI: 10.1084/jem.187.1.129
发表时间: 1998-01-05
影响因子: 15.3
作者:
Bonecchi, R;Bianchi, G;Bordignon, P P;D'Ambrosio, D;Lang, R;Borsatti, A;Sozzani, S;Allavena, P;Gray, P A;Mantovani, A;Sinigaglia, F
通讯作者: Sinigaglia, F